Please assess the completion status of the following clinical trial:

Trial Title: Failed Endometrial Ablation Treatment With Implantable Progesterone (FEAT) Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Previous endometrial ablation~* Pelvic pain and/or vaginal bleeding seeking treatment~Exclusion Criteria:~* Previous or current VTE~* Liver tumour, benign or malignant, or active liver disease~* Undiagnosed abnormal genital bleeding~* Known or suspected breast cancer~* Uncontrolled hypertension~* Allergy to component of etonogestrel implant~* Lack of patient consent

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Etonogestrel implant (Type: EXPERIMENTAL): The participants will receive an etonogestrel 68mg implant

Based on this trial design, predict the completion outcome and termination type (if applicable).